Benzinga | Sep 28, 2021 04:15PM EDT

NeuBase Therapeutics To Present At Chardan Genetic Medicines Conference Oct. 5 At 11:30 a.m. EDT

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase"), a biotechnology platform company Drugging the Genome(tm) to address disease at the base level using a new class of precision genetic medicines, announced today that Dietrich A. Stephan, Ph.D., Chief Executive Officer of NeuBase, will participate in a fireside chat at the virtual Chardan 5th Annual Genetic Medicines Conference being held October 4 - 5.

Chardan 5th Annual Genetic Medicines ConferenceDate: Tuesday, October 5thTime: 11:30 a.m. ETLocation: Webcast link or at the company?s website